CLL Updates from ASH 2023
ASH 2023 Insights: "Effect of Ibrutinib Flexible Dosing Strategies on TTNT in CLL From a Largely Community-Based Claims Database"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Nilanjan Ghosh
By
Insights from 2023 ASH Annual Meeting
FEATURING
Nilanjan Ghosh
Comments 0
Login to view comments.
Click here to Login
